Showing 97,801 - 97,820 results of 102,257 for search '(( 12 wt decrease ) OR ( 5 ((((nn decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.31s Refine Results
  1. 97801

    Table_1_Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma.docx by Johanna Matull (18767917)

    Published 2024
    “…GNAQ and GNA11 mutations were common in uveal melanomas, while MAP-Kinase mutations were frequent in non-uveal melanomas with NF1, BRAF V600 and NRAS Q61 mutations occurring in decreasing frequency, consistent with a strong UV association. …”
  2. 97802

    Data_Sheet_1_Cost-effectiveness of ensartinib, crizotinib, ceritinib, alectinib, brigatinib and lorlatinib in patients with anaplastic lymphoma kinase-positive non-small cell lung... by Xia Luo (169127)

    Published 2022
    “…When compared with lorlatinib and alectinib, ensartinib was associated with a lower QALY and decreased total costs; the ICERs for lorlatinib and alectinib were $934,101/ QALY and $164,888/ QALY, respectively.…”
  3. 97803
  4. 97804
  5. 97805
  6. 97806
  7. 97807
  8. 97808
  9. 97809
  10. 97810
  11. 97811
  12. 97812
  13. 97813
  14. 97814
  15. 97815
  16. 97816
  17. 97817
  18. 97818

    Table1.DOCX by Holly Stolterfoht (4862653)

    Published 2018
    “…A multiple sequence alignment of CARs with confirmed activity recently identified in our lab and from the literature revealed a fingerprint of conserved amino acids. …”
  19. 97819
  20. 97820